These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7902433)

  • 1. Cellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors.
    Suzuki T; Nantel F; Bonin H; Valiquette M; Bouvier M
    J Pharmacol Exp Ther; 1993 Nov; 267(2):785-90. PubMed ID: 7902433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct receptor domains determine subtype-specific coupling and desensitization phenotypes for human beta1- and beta2-adrenergic receptors.
    Rousseau G; Nantel F; Bouvier M
    Mol Pharmacol; 1996 Apr; 49(4):752-60. PubMed ID: 8609905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isoproterenol, denopamine, and atenolol-induced alterations in beta-adrenergic receptor-adenylate cyclase system of rat myocardium].
    Igarashi Y
    Hokkaido Igaku Zasshi; 1991 Sep; 66(5):647-57. PubMed ID: 1683639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable activation and desensitization of beta 2-adrenergic receptor stimulation of adenylyl cyclase by salmeterol: evidence for quasi-irreversible binding to an exosite.
    Clark RB; Allal C; Friedman J; Johnson M; Barber R
    Mol Pharmacol; 1996 Jan; 49(1):182-9. PubMed ID: 8569705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of a human cDNA encoding the beta 2-adrenergic receptor in Chinese hamster fibroblasts (CHW): functionality and regulation of the expressed receptors.
    Bouvier M; Hnatowich M; Collins S; Kobilka BK; Deblasi A; Lefkowitz RJ; Caron MG
    Mol Pharmacol; 1988 Feb; 33(2):133-9. PubMed ID: 2828911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the role of receptor number in defining the intrinsic activity and potency of partial agonists in neuroblastoma x glioma hybrid NG108-15 cells transfected to express differing levels of the human beta 2-adrenoceptor.
    MacEwan DJ; Kim GD; Milligan G
    Mol Pharmacol; 1995 Aug; 48(2):316-25. PubMed ID: 7651365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
    Zeiders JL; Seidler FJ; Slotkin TA
    J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor.
    Chidiac P; Nouet S; Bouvier M
    Mol Pharmacol; 1996 Sep; 50(3):662-9. PubMed ID: 8794908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization.
    Nantel F; Bonin H; Emorine LJ; Zilberfarb V; Strosberg AD; Bouvier M; Marullo S
    Mol Pharmacol; 1993 Apr; 43(4):548-55. PubMed ID: 8386307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Close reciprocal regulation of beta 1- and beta 2-adrenergic receptors by dexamethasone in C6 glioma cells: effects on catecholamine responsiveness.
    Zhong H; Minneman KP
    Mol Pharmacol; 1993 Dec; 44(6):1085-93. PubMed ID: 7903414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of putative beta1-beta2-adrenergic receptor heterodimers.
    Lavoie C; Hébert TE
    Can J Physiol Pharmacol; 2003 Feb; 81(2):186-95. PubMed ID: 12710533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium.
    Bristow MR; Hershberger RE; Port JD; Minobe W; Rasmussen R
    Mol Pharmacol; 1989 Mar; 35(3):295-303. PubMed ID: 2564629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of specific protein kinase C isoforms in modulation of beta1- and beta2-adrenergic receptors.
    Guimond J; Mamarbachi AM; Allen BG; Rindt H; Hébert TE
    Cell Signal; 2005 Jan; 17(1):49-58. PubMed ID: 15451024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On minimum cyclic AMP formation rates associated with positive inotropic effects mediated through beta 1-adrenoceptors in kitten myocardium. Beta 1-specific and non-adrenergic stimulant effects of denopamine.
    Lemoine H; Teng KJ; Slee SJ; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):113-28. PubMed ID: 2566921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular mechanisms of regulatory action of adrenergic receptor agonists on functional activity of adenylyl cyclase signaling system of the ciliates Dileptus anser and Tetrahymena pyriformis].
    Shpakov AO; Derkach KV; Uspenskaia ZI; Shpakova EA; Kuznetsova LA; Plesneva SA; Pertseva MN
    Tsitologiia; 2004; 46(4):317-25. PubMed ID: 15346790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between intrinsic activities of agonists in normal and desensitized tissue and agonist-induced loss of beta adrenergic receptors.
    Pittman RN; Reynolds EE; Molinoff PB
    J Pharmacol Exp Ther; 1984 Sep; 230(3):614-8. PubMed ID: 6147404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta 2-adrenergic receptor regulation of the cardiac L-type Ca2+ channel coexpressed in a fibroblast cell line.
    Masaki H; Green SA; Heiny JA; Yatani A
    Receptor; 1995; 5(4):219-31. PubMed ID: 8840400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of the beta-adrenergic receptor subtypes expressed by CA1 pyramidal cells in the rat hippocampus.
    Hillman KL; Doze VA; Porter JE
    J Pharmacol Exp Ther; 2005 Aug; 314(2):561-7. PubMed ID: 15908513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intact cell binding properties of cells expressing altered beta-adrenergic receptors.
    Zhu SJ; Toews ML
    Mol Pharmacol; 1994 Feb; 45(2):255-61. PubMed ID: 7906855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
    Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
    Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.